Login / Signup

The Allergic Rhinitis Clinical Investigator Collaborative (AR-CIC): verification of nasal allergen challenge procedures in a study utilizing an investigational immunotherapy for cat allergy.

Helen NeighbourMena SolimanLisa M SteacyPascal HickeyBeth ForbesMark LarchéAnne K Ellis
Published in: Clinical and translational allergy (2018)
This study supports the validity of the AR-CIC's optimised NAC protocol for conducting research of the potential efficacy of novel therapeutics in multi-centre studies.Trial registration Both studies reported herein were registered clinicaltrials.gov (NCT01383590 and NCT01383603).
Keyphrases
  • allergic rhinitis
  • phase ii
  • case control
  • randomized controlled trial
  • transcription factor
  • clinical trial
  • small molecule
  • study protocol
  • quality improvement
  • phase iii
  • risk assessment
  • open label
  • infectious diseases